Viral infections may trigger Parkinson's disease, CCMB study suggests

Research conducted at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has established a connection between certain viral infections and the development of Parkinson's disease, a progressive neurodegenerative disorder affecting millions globally. The study examined how pathogens such as influenza and SARS-CoV-2—the virus responsible for COVID-19—may contribute to the disease's onset or progression.

Parkinson's disease is characterized by the degeneration of dopamine-producing neurons in the brain, leading to tremors, rigidity, and movement difficulties. While the exact causes remain incompletely understood, genetic factors and environmental triggers have long been considered significant contributors to disease development. The CCMB findings add viral infection to the list of potential environmental risk factors.

The implications of this research extend beyond basic science, potentially offering new avenues for understanding disease mechanisms and developing preventive strategies. Given the widespread prevalence of influenza and the recent global COVID-19 pandemic, the findings underscore the importance of investigating long-term neurological consequences of viral infections.

The study aligns with emerging evidence from other research institutions suggesting links between viral pathogens and neurodegenerative diseases. Further investigations are expected to clarify the molecular mechanisms by which these infections might damage neural tissue and trigger Parkinson's-like symptoms in susceptible individuals.